Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.
about
Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.[Drug-drug interactions: interactions between xenobiotics].Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.
P2860
Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Improved ziprasidone formulati ...... ate and a reduced food effect.
@en
Improved ziprasidone formulati ...... ate and a reduced food effect.
@nl
type
label
Improved ziprasidone formulati ...... ate and a reduced food effect.
@en
Improved ziprasidone formulati ...... ate and a reduced food effect.
@nl
prefLabel
Improved ziprasidone formulati ...... ate and a reduced food effect.
@en
Improved ziprasidone formulati ...... ate and a reduced food effect.
@nl
P2093
P2860
P1476
Improved ziprasidone formulati ...... ate and a reduced food effect.
@en
P2093
Avinash G Thombre
Jeffrey A Alderman
Scott M Herbig
P2860
P304
P356
10.1007/S11095-011-0505-7
P577
2011-06-15T00:00:00Z